Mojoon Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.8/10
Best for: Chinese-speaking patients who want a bilingual telehealth service
Mojoon scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $350 a month; its compounded tirzepatide, at $390, is 45% above the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Mojoon is a Chinese-language telehealth platform for Chinese-speaking US residents, run by Mojoon Inc. It sells compounded semaglutide injections from $350 a month, tirzepatide from $390 and semaglutide sublingual drops at $400, with the price rising as the dose does. Doctors are licensed in 48 states; New Mexico and Mississippi are excluded.
Is Mojoon legit?
Yes. Mojoon is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 6.8/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Mojoon promo or coupon code?
We know of no promo or coupon code for Mojoon. Its listed price is $350 a month. Coupon sites advertising "Mojoon discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Mojoon compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Mojoon
Editorial score · methodology
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Editorial score · methodology
Mojoon at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $350/mo
- What's included
- Medication · Shipping
- Availability
- 48 states
- FDA status
- No FDA warning letters found
How Mojoon scores
Six columns, each one computed from something Mojoon has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
2.3/10$390/month is 45% above the $269 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
7.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
9.7/10Serves 48 of 50 states.
Support10%
4.5/10The price covers the medication and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Mojoon
Last checked October 2026- Checked the listed price across 3 dose or plan tiers
- Checked state coverage: 48 states
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Mojoon
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Mojoon involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Mojoon shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Mojoon which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication and shipping.
- Lowest ongoing monthly price: semaglutide $350, tirzepatide $390. That leaves out membership fees, first-month rates and insurance copays.
- Mojoon serves 48 of 50 states, so check that yours is one of them.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Mojoon
- Phone
- 909-660-6656
- Mojoon offers email support
- Hours
- M-F 9:30am-5pm PST
Cancelling Mojoon
Taken from the terms Mojoon publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None
- Refund policy
- Refund only if you cancel before the medication ships
Medications Mojoon lists
Mojoon lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
$350 to $520 per monthly course, shown against a struck-through $1000.
$390 to $490 per monthly course.
$400 per course, shown against a struck-through $900.
Check the price yourself before you pay
Every figure here comes from Mojoon's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication and shipping
- Serves 48 states
- We found no FDA warning letters issued to Mojoon
Against it
- Semaglutide costs $350 a month, 76% above the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $390 a month, 45% above the $269 median for compounded tirzepatide across the sellers we compare
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Mojoon charges
Mojoon lists $350/month.
- Compounded semaglutide (injection): $350/month
- Compounded tirzepatide: $390/month
- Compounded semaglutide (oral drops): $400/month
For compounded tirzepatide, the median across the sellers we compare is $269/month, so Mojoon's $390 is a premium, and a premium has to buy something. Check what is bundled before you accept it. Before you pay, compare Mojoon's cancellation terms with other sellers' cancellation and refund policies.
MangoRx dispenses semaglutide and tirzepatide from $299/month, which makes it the fair comparison to run before you commit here.
What Mojoon dispenses
Mojoon prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy. Some of Mojoon's preparations are mixed with B12; why compounders add it separates what is established from what is only claimed.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Mojoon at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot. No human absorption study of sublingual semaglutide drops has been published.
Safety and disclosure
Mojoon tells you its price before you start the medical questionnaire and the 48 states it serves. We found no FDA warning letters issued to Mojoon. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Mojoon will not tell you, treat that as a warning sign. Once you have the pharmacy's name, 503A vs 503B explains which regulator oversees it and how to check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Mojoon bills your plan before you start.
It fits if
- injections are the thing keeping you from starting
Our read
Mojoon costs more than the middle of this market, and the oral option is the clearest thing that premium buys. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less.
The Bottom Line
Mojoon scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $350 a month; its compounded tirzepatide, at $390, is 45% above the $269 median among the sellers we compare.
Before you pay Mojoon
Starting at $350 a month. Check today's price, then start the intake.
Where Mojoon is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to Mojoon sets more sellers in the same category beside Mojoon on price, states and what the price includes.
Frequently Asked Questions
How to check Mojoon yourself
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- How to Get a GLP-1 Prescription
- FDA Warning Letters to Peptide Sellers: What FDA Has Cited, 2023 to 2026
Every seller that ships to your state, side by side: California, Delaware, Massachusetts, Minnesota, Nebraska, Nevada, Oklahoma, Utah and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Mojoon review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Mojoon's current pricing
Plans start at $350 a month. Whether you qualify is a clinician's decision, made after your intake.